Main content

US drug companies and the NHS

Is Britain's health service really up for sale?

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the ±«Óãtv's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)

Available now

18 minutes

Last on

Mon 9 Dec 2019 13:32GMT

Broadcasts

  • Mon 9 Dec 2019 08:32GMT
  • Mon 9 Dec 2019 13:32GMT

Business Daily Podcast

Download every programme.

Podcast